The Latest Cardiac and Vascular News
BEDFORD, Mass.–(BUSINESS WIRE)–SpectraWAVE, Inc., a medical imaging company focused on improving the treatment and outcomes for patients with coronary artery disease (CAD), today announced the addition of two seasoned executives to its leadership team. Brad Davis has been named Chief Commercial Officer (CCO), and Bill Kelly has been named Chief […]
New York, January 9, 2025: The world’s most adopted healthcare AI company, Qure.ai, has appointed a new Chief Commercial Officer to oversee and expand global sales and business development strategy. Based in New York, Jim Mercadante joins a growing commercial and operations team to consolidate growing momentum and orchestrate further […]
LONG BEACH, Calif., Jan. 9, 2025 /PRNewswire/ — Christina Rodriguez, M.D., has been named medical director of advanced cardiac imaging at MemorialCare Heart & Vascular Institute at Long Beach Medical Center. Dr. Rodriguez is a fellowship-trained, board-certified, non-invasive…
orthStar to support the development of YAP Therapeutics’ innovative radiolabeled products This collaboration merges the expertise and resources from both companies, including NorthStar’s state-of-the-art facilities The agreement guarantees that YAP Therapeutics will receive clinical trial-ready doses of its novel products in development January 08, 2025 08:01 AM Eastern Standard Time […]
Over 90 patients have received the Aeson® artificial heart since the first implant in 2013, including 42 in 2024. 2024 Sales of €7 million (a 2.5-fold increase vs 2023). Cash burn reduced by over 20% vs 2023. 50 hospitals trained in Aeson® implants internationally1. Successful first “Aeson® User Meeting” and […]
BURLINGTON, Mass.–(BUSINESS WIRE)–Cardurion Pharmaceuticals, Inc. (“Cardurion”), a clinical-stage biotechnology company discovering and developing new therapeutic approaches for the treatment of cardiovascular diseases, today announced that Charlotte (Charlie) Newman has joined the company as Chief Business Officer. A biopharmaceutical industry executive with over 25 years of industry experience, Ms. Newman most recently […]
IRVINE, Calif., Jan. 8, 2025 /PRNewswire/ — Relief Cardiovascular, an inQB8 Medical Technologies portfolio company pioneering innovative solutions for the management of heart failure, today announced the closing of a $12M Series A financing. The funding round was co-led by Broadview…
Acquisition to expand cardiovascular portfolio with complementary and differentiated calcium modification platform, furthering company’s strategy to address coronary and peripheral disease MARLBOROUGH, Mass., Jan. 8, 2025 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today…
DUBLIN–(BUSINESS WIRE)–FIRE1, a leading connected medical device solutions company, today announced the successful completion of a $120 million financing round to accelerate the company’s mission to transform the lives of millions of people living with heart failure. “From the beginning, our team has been driven by two core goals: creating […]
January 07, 2025 07:30 AM Eastern Standard Time KING OF PRUSSIA, Pa.–(BUSINESS WIRE)–XyloCor Therapeutics, Inc., (“XyloCor”), a clinical stage biopharmaceutical company developing novel gene therapies for cardiovascular disease, today announced the completion of a $67.5 million Series B financing. New investment will support a randomized, double-blind Phase 2b clinical trial […]
